相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The Yin and Yang of High-density Lipoprotein and Atherosclerotic Cardiovascular Disease: Focusing on Functionality and Cholesterol Efflux to Reframe the HDL Hypothesis
Shiva Ganjali et al.
CURRENT MEDICINAL CHEMISTRY (2021)
Serum lipids and prostate cancer
Manuel M. Garrido et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)
Artesunate inhibits the mevalonate pathway and promotes glioma cell senescence
Shupei Wei et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Statin use is associated with improved survival in multiple myeloma: A Swedish population-based study of 4315 patients
Elsa Branvall et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Mechanisms and regulation of cholesterol homeostasis
Jie Luo et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Modifiable pathways for colorectal cancer: a mendelian randomisation analysis
Alex J. Cornish et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Cholesterol and beyond - The role of the mevalonate pathway in cancer biology
Andy Goebel et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
HDL-C is associated with mortality from all causes, cardiovascular disease and cancer in a J-shaped dose-response fashion: a pooled analysis of 37 prospective cohort studies
Guo-Chao Zhong et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
The association of serum lipid levels with colorectal cancer recurrence
Kristen D. Brantley et al.
CANCER EPIDEMIOLOGY (2020)
Use of Biomarkers and Imaging for Early Detection of Pancreatic Cancer
Shingo Kato et al.
CANCERS (2020)
ApoC1 promotes the metastasis of clear cell renal cell carcinoma via activation of STAT3
Yang-ling Li et al.
ONCOGENE (2020)
Cholesterol metabolism: At the cross road between cancer cells and immune environment
Joanna Kopecka et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2020)
The Structure and Function of Paraoxonase-1 and Its Comparison to Paraoxonase-2 and-3
Ajda Taler-Vercic et al.
MOLECULES (2020)
Associations between cardiovascular disease, cancer, and very low high-density lipoprotein cholesterol in the REasons for Geographical and Racial Differences in Stroke (REGARDS) study
Peter Penson et al.
CARDIOVASCULAR RESEARCH (2019)
A Newly Integrated Model for Intestinal Cholesterol Absorption and Efflux Reappraises How Plant Sterol Intake Reduces Circulating Cholesterol Levels
Takanari Nakano et al.
NUTRIENTS (2019)
Correlation between immune signature and high-density lipoprotein cholesterol level in stage II/III colorectal cancer
Yun Wang et al.
CANCER MEDICINE (2019)
Anti-tumorigenic and Platinum-Sensitizing Effects of Apolipoprotein A1 and Apolipoprotein A1 Mimetic Peptides in Ovarian Cancer
Aline T. Marinho et al.
FRONTIERS IN PHARMACOLOGY (2019)
Intestinal PPARα Protects Against Colon Carcinogenesis via Regulation of Methyltransferases DNMT1 and PRMT6
Yuhong Luo et al.
GASTROENTEROLOGY (2019)
Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma
Jean-Louis Jouve et al.
JOURNAL OF HEPATOLOGY (2019)
HDL and LDL: Potential New Players in Breast Cancer Development
Lidia Cedo et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer
Konstantina Georgila et al.
CANCERS (2019)
SREBP-1 inhibitor Betulin enhances the antitumor effect of Sorafenib on hepatocellular carcinoma via restricting cellular glycolytic activity
Fan Yin et al.
CELL DEATH & DISEASE (2019)
Highlight article: The role of cholesterol and cholesterol-driven membrane raft domains in prostate cancer
Anita Hryniewicz-Jankowska et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2019)
Mendelian randomization analysis rules out disylipidaemia as colorectal cancer cause
Gemma Ibanez-Sanz et al.
SCIENTIFIC REPORTS (2019)
Statin-Induced Nitric Oxide Signaling: Mechanisms and Therapeutic Implications
Armita Mahdavi Gorabi et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE study
Juzar Jamnagerwalla et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2018)
LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer
Masoud F. Tavazoie et al.
CELL (2018)
Paraoxonase-1 activity in patients with cancer: A systematic review and meta-analysis
M. Arenas et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Atorvastatin Versus Placebo for Prostate Cancer Before Radical Prostatectomy-A Randomized, Double-blind, Placebo-controlled Clinical Trial
Teemu J. Murtola et al.
EUROPEAN UROLOGY (2018)
Lipid pathway deregulation in advanced prostate cancer
Laura Galbraith et al.
PHARMACOLOGICAL RESEARCH (2018)
Lipophilic statins limit cancer cell growth and survival, via involvement of Akt signaling
Colin H. Beckwitt et al.
PLOS ONE (2018)
Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer
Yang-An Wen et al.
CELL DEATH & DISEASE (2018)
Identification of serum proteins AHSG, FGA and APOA-I as diagnostic biomarkers for gastric cancer
Feiyu Shi et al.
CLINICAL PROTEOMICS (2018)
ABCA1 overexpression worsens colorectal cancer prognosis by facilitating tumour growth and caveolin-1-dependent invasiveness, and these effects can be ameliorated using the BET inhibitor apabetalone
Cristina Aguirre-Portoles et al.
MOLECULAR ONCOLOGY (2018)
Significance of LDL and HDL subclasses characterization in the assessment of risk for colorectal cancer development
Milica Stevanovic et al.
BIOCHEMIA MEDICA (2018)
Emodin Sensitizes Hepatocellular Carcinoma Cells to the Anti-Cancer Effect of Sorafenib through Suppression of Cholesterol Metabolism
Young-Seon Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
HDL in Endocrine Carcinomas: Biomarker, Drug Carrier, and Potential Therapeutic
Emily E. Morin et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
The interplay between mutant p53 and the mevalonate pathway
Alejandro Parrales et al.
CELL DEATH AND DIFFERENTIATION (2018)
Blood cholesterol, tumor clinical characteristics and risk of prostate cancer progression after radical prostatectomy
Lauri Rantaniemi et al.
SCANDINAVIAN JOURNAL OF UROLOGY (2018)
The role of the Hedgehog signaling pathway in cancer: A comprehensive review
Ana Marija Skoda et al.
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES (2018)
mTORC1 and mTORC2 in cancer and the tumor microenvironment
L. C. Kim et al.
ONCOGENE (2017)
Secondary bile acid-induced dysbiosis promotes intestinal carcinogenesis
Hailong Cao et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Identification of differentially expressed proteins in retinoblastoma tumors using mass spectrometry-based comparative proteomic approach
Jasmine Naru et al.
JOURNAL OF PROTEOMICS (2017)
Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia
E. J. Gallagher et al.
ONCOGENE (2017)
CHOLESTEROL SENSING Lysosomal cholesterol activates mTORC1 via an SLC38A9-Niemann-Pick C1 signaling complex
Brian M. Castellano et al.
SCIENCE (2017)
Randomized Phase II Study of Afatinib Plus Simvastatin Versus Afatinib Alone in Previously Treated Patients with Advanced Nonadenocarcinomatous Non-small Cell Lung Cancer
Youngjoo Lee et al.
CANCER RESEARCH AND TREATMENT (2017)
Cholesterol Enhances Colorectal Cancer Progression via ROS Elevation and MAPK Signaling Pathway Activation
Caihua Wang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
HDL cholesterol: reappraisal of its clinical relevance
Winfried Maerz et al.
CLINICAL RESEARCH IN CARDIOLOGY (2017)
The balance between induction and inhibition of mevalonate pathway regulates cancer suppression by statins: A review of molecular mechanisms
Yasin Ahmadi et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
Sterol regulatory element-binding protein 1 inhibitors decrease pancreatic cancer cell viability and proliferation
Siqingaowa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Pleiotropic Effects of Statins on the Cardiovascular System
Adam Oesterle et al.
CIRCULATION RESEARCH (2017)
Identification of Differentially Expressed Proteins in the Serum of Colorectal Cancer Patients Using 2D-DIGE Proteomics Analysis
Lay Cheng Lim et al.
PATHOLOGY & ONCOLOGY RESEARCH (2016)
Cholesterol Biosynthesis: A Mechanistic Overview
Nuno M. F. S. A. Cerqueira et al.
BIOCHEMISTRY (2016)
Potential usefulness of apolipoprotein A2 isoforms for screening and risk stratification of pancreatic cancer
Kazufumi Honda et al.
BIOMARKERS IN MEDICINE (2016)
Diagnostic and prognostic significance of serum apolipoprotein C-I in triple-negative breast cancer based on mass spectrometry
Dongjian Song et al.
CANCER BIOLOGY & THERAPY (2016)
mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells
Raju V. Pusapati et al.
CANCER CELL (2016)
The Effect of Atorvastatin on Breast Cancer Biomarkers in High-Risk Women
YongLi Ji et al.
CANCER PREVENTION RESEARCH (2016)
Statins in the chemoprevention of colorectal cancer in established animal models of sporadic and colitis-associated cancer
Emmanouil Pikoulis et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2016)
Apolipoproteins, lipids and risk of cancer
Signe Borgquist et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Fatostatin Inhibits Cancer Cell Proliferation by Affecting Mitotic Microtubule Spindle Assembly and Cell Division
Ankur A. Gholkar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Statin use and the risk of colorectal adenoma: A meta-analysis
Yoon Suk Jung et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Fatostatin blocks ER exit of SCAP but inhibits cell growth in a SCAP-independent manner
Wei Shao et al.
JOURNAL OF LIPID RESEARCH (2016)
Srebp2: A master regulator of sterol and fatty acid synthesis
Blair B. Madison
JOURNAL OF LIPID RESEARCH (2016)
Statin attenuates cell proliferative ability via TAZ (WWTR1) in hepatocellular carcinoma
Takaaki Higashi et al.
MEDICAL ONCOLOGY (2016)
Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism
Wei Yang et al.
NATURE (2016)
DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway
Alejandro Parrales et al.
NATURE CELL BIOLOGY (2016)
Control of the innate immune response by the mevalonate pathway
Murali K. Akula et al.
NATURE IMMUNOLOGY (2016)
Up-regulated expression of scavenger receptor class B type 1 (SR-B1) is associated with malignant behaviors and poor prognosis of breast cancer
Juan Li et al.
PATHOLOGY RESEARCH AND PRACTICE (2016)
Apolipoprotein A1: a novel serum biomarker for predicting the prognosis of hepatocellular carcinoma after curative resection
Xiao-Lu Ma et al.
ONCOTARGET (2016)
ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer
Lidia Cedo et al.
SCIENTIFIC REPORTS (2016)
Effect of Lipophilic and Hydrophilic Statins on Breast Cancer Risk in Thai Women: A Cross-sectional Study
Thunyarat Anothaisintawee et al.
JOURNAL OF CANCER (2016)
Identification of Apolipoprotein C-I Peptides as a Potential Biomarker and its Biological Roles in Breast Cancer
Yadong Sun et al.
MEDICAL SCIENCE MONITOR (2016)
SR-BI: Linking Cholesterol and Lipoprotein Metabolism with Breast and Prostate Cancer
Jorge L. Gutierrez-Pajares et al.
FRONTIERS IN PHARMACOLOGY (2016)
Mitochondria, cholesterol and cancer cell metabolism
Vicent Ribas et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2016)
Elevated Levels of StAR-Related Lipid Transfer Protein 3 Alter Cholesterol Balance and Adhesiveness of Breast Cancer Cells Potential Mechanisms Contributing to Progression of HER2-Positive Breast Cancers
Boris Vassilev et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Slc10a2-null mice uncover colon cancer-promoting actions of endogenous fecal bile acids
Jean-Pierre Raufman et al.
CARCINOGENESIS (2015)
Global Transcriptional Changes Following Statin Treatment in Breast Cancer
Olof Bjarnadottir et al.
CLINICAL CANCER RESEARCH (2015)
Dendrogenin A: A Mammalian Metabolite of Cholesterol with Tumor Suppressor and Neurostimulating Properties
Florence Dalenc et al.
CURRENT MEDICINAL CHEMISTRY (2015)
Acetyl-CoA and the regulation of metabolism: mechanisms and consequences
Lei Shi et al.
CURRENT OPINION IN CELL BIOLOGY (2015)
Serum Lipids, Lipoproteins, and Risk of Breast Cancer: A Nested Case-Control Study Using Multiple Time Points
Lisa J. Martin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial
Maria Feldt et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Oxidized low-density lipoprotein is associated with advanced-stage prostate cancer
Fangning Wan et al.
TUMOR BIOLOGY (2015)
A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-C
Fangxin Liao et al.
ONCOTARGETS AND THERAPY (2015)
Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-All isoforms
Kazufumi Honda et al.
SCIENTIFIC REPORTS (2015)
Serum Lipids, Lipoproteins, and Risk of Breast Cancer: A Nested Case-Control Study Using Multiple Time Points
Lisa J. Martin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Statins and Cancer
Natalia G. Vallianou et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2014)
Significant Association of Metabolic Indices, Lipid Profile, and Androgen Levels with Prostate Cancer
Reshu Tewari et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breast tumor progression
Catarina Rodrigues dos Santos et al.
BMC CANCER (2014)
Colorectal cancer risk and dyslipidemia: A case-cohort study nested in an Italian multicentre cohort
Claudia Agnoli et al.
CANCER EPIDEMIOLOGY (2014)
LXR-dependent and -independent effects of oxysterols on immunity and tumor growth
Catia Traversari et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
HIF Transcription Factors, Inflammation, and Immunity
Asis Palazon et al.
IMMUNITY (2014)
Identification of Apolipoprotein C-I as a Potential Wilms' Tumor Marker after Excluding Inflammatory Factors
Junjie Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Statin Drug Use is Not Associated with Prostate Cancer Risk in Men Who are Regularly Screened
Elizabeth A. Platz et al.
JOURNAL OF UROLOGY (2014)
Fatostatin Displays High Antitumor Activity in Prostate Cancer by Blocking SREBP-Regulated Metabolic Pathways and Androgen Receptor Signaling
Xiangyan Li et al.
MOLECULAR CANCER THERAPEUTICS (2014)
LDL-cholesterol signaling induces breast cancer proliferation and invasion
Catarina Rodrigues dos Santos et al.
LIPIDS IN HEALTH AND DISEASE (2014)
Statin Use Is Not Associated with Improved Progression Free Survival in Cetuximab Treated KRAS Mutant Metastatic Colorectal Cancer Patients: Results from the CAIRO2 Study
Lisanne L. Krens et al.
PLOS ONE (2014)
Novel prospects of statins as therapeutic agents in cancer
Simona Pisanti et al.
PHARMACOLOGICAL RESEARCH (2014)
Cholesterol and Cancer, in the Balance
Sandrine Silvente-Poirot et al.
SCIENCE (2014)
Lipid levels in serum and cancerous tissues of colorectal cancer patients
Xin Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy
Chun Chao et al.
BJU INTERNATIONAL (2013)
Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial
Olof Bjarnadottir et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils
Laura Raccosta et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Identification of potential bladder cancer markers in urine by abundant-protein depletion coupled with quantitative proteomics
Chien-Lun Chen et al.
JOURNAL OF PROTEOMICS (2013)
Sterol regulatory element-binding protein 1 is required for ovarian tumor growth
Long-Yun Nie et al.
ONCOLOGY REPORTS (2013)
27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology
Erik R. Nelson et al.
SCIENCE (2013)
Prenyltransferase inhibitors: treating human ailments from cancer to parasitic infections
Joshua D. Ochocki et al.
MEDCHEMCOMM (2013)
Dendrogenin A arises from cholesterol and histamine metabolism and shows cell differentiation and anti-tumour properties
Philippe de Medina et al.
NATURE COMMUNICATIONS (2013)
27-Hydroxycholesterol Promotes Cell-Autonomous, ER-Positive Breast Cancer Growth
Qian Wu et al.
CELL REPORTS (2013)
Bile Acid Metabolism and Signaling
John Y. L. Chiang
COMPREHENSIVE PHYSIOLOGY (2013)
A key regulator of cholesterol homoeostasis, SREBP-2, can be targeted in prostate cancer cells with natural products
James R. Krycer et al.
BIOCHEMICAL JOURNAL (2012)
Plasma total, LDL, and HDL cholesterol and risk of aggressive prostate cancer in the Cancer Prevention Study II Nutrition Cohort
Eric J. Jacobs et al.
CANCER CAUSES & CONTROL (2012)
A Comprehensive Survey of Ras Mutations in Cancer
Ian A. Prior et al.
CANCER RESEARCH (2012)
Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
William A. Freed-Pastor et al.
CELL (2012)
p53 and cancer stem cells The mevalonate connexion
Christophe Ginestier et al.
CELL CYCLE (2012)
Cholesterol and its derivatives in Sonic Hedgehog signaling and cancer
Natalia A. Riobo
CURRENT OPINION IN PHARMACOLOGY (2012)
Cholesterol and prostate cancer
Kristine Pelton et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
Simvastatin inhibits cancer cell growth by inducing apoptosis correlated to activation of Bax and down-regulation of BCL-2 gene expression
Carmine Spampanato et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
HDL Mimetics Inhibit Tumor Development in Both Induced and Spontaneous Mouse Models of Colon Cancer
Feng Su et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Association Between Low Colonic Short-Chain Fatty Acids and High Bile Acids in High Colon Cancer Risk Populations
Junhai Ou et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2012)
Use of Fibrates and Cancer Risk: A Systematic Review and Meta-Analysis of 17 Long-Term Randomized Placebo-Controlled Trials
Stefanos Bonovas et al.
PLOS ONE (2012)
Mevalonate Metabolism Regulates Basal Breast Cancer Stem Cells and Is a Potential Therapeutic Target
Christophe Ginestier et al.
STEM CELLS (2012)
Synergistic Effect of Geranylgeranyltransferase Inhibitor, GGTI, and Docetaxel on the Growth of Prostate Cancer Cells
Bin Han et al.
PROSTATE CANCER (2012)
Diet-induced weight loss reduces colorectal inflammation: implications for colorectal carcinogenesis
Swaroop Pendyala et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)
The Akt signaling pathway An emerging therapeutic target in malignant melanoma
SubbaRao V. Madhunapantula et al.
CANCER BIOLOGY & THERAPY (2011)
Akt Stimulates Hepatic SREBP1c and Lipogenesis through Parallel mTORC1-Dependent and Independent Pathways
Jessica L. Yecies et al.
CELL METABOLISM (2011)
L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways
Feng Gao et al.
INTEGRATIVE BIOLOGY (2011)
Statin-induced apoptosis via the suppression of ERK1/2 and Akt activation by inhibition of the geranylgeranyl-pyrophosphate biosynthesis in glioblastoma
Masashi Yanae et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Relationship Between Statin Use and Colon Cancer Recurrence and Survival: Results From CALGB 89803
Kimmie Ng et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Lovastatin Sensitizes Lung Cancer Cells to Ionizing Radiation Modulation of Molecular Pathways of Radioresistance and Tumor Suppression
Toran Sanli et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Serum Apolipoproteins C-I and C-III Are Reduced in Stomach Cancer Patients: Results from MALDI-Based Peptidome and Immuno-Based Clinical Assays
Meital Cohen et al.
PLOS ONE (2011)
ApoB/apoA1 is an effective predictor of coronary heart disease risk in overweight and obesity
Min Lu et al.
JOURNAL OF BIOMEDICAL RESEARCH (2011)
Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids
Yasemin Sancak et al.
CELL (2010)
NPC1L1 and cholesterol transport
Jenna L. Betters et al.
FEBS LETTERS (2010)
LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression
Jonathan E. Feig et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses
Eduardo J. Villablanca et al.
NATURE MEDICINE (2010)
Identification and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and AEBS ligands
Philippe de Medina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer
Feng Su et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Ezetimibe Is an Inhibitor of Tumor Angiogenesis
Keith R. Solomon et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
How ERK1/2 activation controls cell proliferation and cell death is subcellular localization the answer?
Yohannes Mebratu et al.
CELL CYCLE (2009)
Lysophosphatidic acid stimulates cell migration, invasion, and colony formation as well as tumorigenesis/metastasis of mouse ovarian cancer in immunocompetent mice
Hui Li et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Proteomic Identification of Serum Biomarkers for Head and Neck Cancer Surveillance
Christine G. Gourin et al.
LARYNGOSCOPE (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
EGFR Signaling Through an Akt-SREBP-1-Dependent, Rapamycin-Resistant Pathway Sensitizes Glioblastomas to Antilipogenic Therapy
Deliang Guo et al.
SCIENCE SIGNALING (2009)
Detection and Identification of Potential Biomarkers of Non-small Cell Lung Cancer
Yang Yang et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2009)
ProApoliploprotein A1 - A serum marker of brain metastases in lung cancer patient
Nicola Marchi et al.
CANCER (2008)
Hypercholesterolemia and prostate cancer: a hospital-based case-control study
Lindsay Magura et al.
CANCER CAUSES & CONTROL (2008)
Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma
Joan Montero et al.
CANCER RESEARCH (2008)
Apolipoprotein C-1 maintains cell survival by preventing from apoptosis in pancreatic cancer cells
S. Takano et al.
ONCOGENE (2008)
Statin-induced breast cancer cell death: Role of inducible nitric oxide and arginase-dependent pathways
Srigiridhar Kotamraju et al.
CANCER RESEARCH (2007)
Simvastatin induces apoptosis in human breast cancer cells: p53 and estrogen receptor independent pathway requiring signalling through JNK
Meral Koyuturk et al.
CANCER LETTERS (2007)
Molecular regulation of HDL metabolism and function: implications for novel therapies
Daniel J. Rader
JOURNAL OF CLINICAL INVESTIGATION (2006)
Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells
Umasundari Sivaprasad et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Breast cancer growth prevention by statins
Michael J. Campbell et al.
CANCER RESEARCH (2006)
Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry
Judith Y. M. N. Engwegen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors
KR Cheng et al.
BIOCHEMICAL PHARMACOLOGY (2005)
New insights into the regulation of HDL metabolism and reverse cholesterol transport
GF Lewis et al.
CIRCULATION RESEARCH (2005)
Statins and the risk of colorectal cancer
JN Poynter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Activation and signaling of the p38 MAP kinase pathway
T Zarubin et al.
CELL RESEARCH (2005)
Involvement of cholesterol-rich lipid rafts in interleukin-6-induced neuroendocrine differentiation of LNCaP prostate cancer cells
JY Kim et al.
ENDOCRINOLOGY (2004)
Hedgehog signalling in prostate regeneration, neoplasia and metastasis
SS Karhadkar et al.
NATURE (2004)
Bile acids mimic oxidative stress induced upregulation of thioredoxin reductase in colon cancer cell lines
S Lechner et al.
CARCINOGENESIS (2002)
3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis
T Kusama et al.
GASTROENTEROLOGY (2002)
Role of prenylation in the interaction of Rho-family small GTPases with GTPase activating proteins
G Molnár et al.
BIOCHEMISTRY (2001)
Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells
YL Hu et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Structural mechanism for statin inhibition of HMG-CoA reductase
ES Istvan et al.
SCIENCE (2001)